Clinical Trials (Industry Perspective)

Sep 26, 2016 by in PEDIATRICS Comments Off on Clinical Trials (Industry Perspective)

•S upervise : all aspects of the trial are ultimately the responsible of the investigator •M aintain Records : meticulous record keeping is critically important •A dhere to the protocol…

read more

Pouchitis After Ileal Pouch-Anal Anastomosis

Sep 26, 2016 by in PEDIATRICS Comments Off on Pouchitis After Ileal Pouch-Anal Anastomosis

Immunosuppression Bacterial overgrowth Fecal stasis Nutritional Mucosal ischemia Crohn disease, undiagnosed Severity of UC Extraintestinal manifestations, including primary sclerosing cholangitis Smoking pANCA Immune Dysregulation One of the most pursued areas…

read more

Biologic Therapies

Sep 26, 2016 by in PEDIATRICS Comments Off on Biologic Therapies

Anti-tumor necrosis factor Adalimumab Monoclonal antibody Crohn disease Approved phase III Ulcerative colitis  Certolizumab pegol Pegylated antibody fragment Crohn disease Approved phase III  Golimumab Monoclonal antibody Ulcerative colitis Phase III …

read more

Probiotic Therapy

Sep 26, 2016 by in PEDIATRICS Comments Off on Probiotic Therapy

Participants (# treated) Trial design Probiotic (strains) Dosing (CFU/day) Trial length (weeks) Ref. 20 (10) EBRPC Blend Probiotic (Yakult™) 1  ×  1010 12 [25] 102 (52) DBRDD Single strain (E….

read more

Transition from Pediatric to Adult Care

Sep 26, 2016 by in PEDIATRICS Comments Off on Transition from Pediatric to Adult Care

Disease information: date of diagnosis, location, severity Findings: Laboratories, Endoscopy, Histology, Radiology results, and dates Medical therapies: dose, duration, adverse reactions, reasons for discontinuation Surgeries Adapted from Hait et al….

read more

Legislative Advocacy

Sep 26, 2016 by in PEDIATRICS Comments Off on Legislative Advocacy

Petar Mamula, Jonathan E. Markowitz and Robert N. Baldassano (eds.)Pediatric Inflammatory Bowel Disease2nd ed. 201310.1007/978-1-4614-5061-0_52© Springer Science+Business Media New York 2013 52. Legislative Advocacy Suzanne Rosenthal1   and Crohn’s & Colitis Foundation of America (1) Crohn’s and Colitis…

read more

5-Aminosalicylate Therapy

Sep 26, 2016 by in PEDIATRICS Comments Off on 5-Aminosalicylate Therapy

Drug Formulation Delivery system Dosage form Release location Azo-bonded formulations Sulfasalazine (Azulfidine®) Azo bond of 5-ASA to sulfapyridine Broken down by colonic bacteria to release active 5-ASA moiety Tablet 500…

read more
Get Clinical Tree app for offline access